Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.38 USD | +1.96% | +2.85% | +16.96% |
Mar. 13 | Trump floats billionaire Paulson as potential Treasury chief, Bloomberg reports | RE |
Mar. 06 | Bausch Health's Salix Pharmaceuticals Announces Phase 2 Investigator-Initiated Study of Relistor | MT |
Financials (USD)
Sales 2024 * | 9.39B | Sales 2025 * | 9.21B | Capitalization | 3.43B |
---|---|---|---|---|---|
Net income 2024 * | 220M | Net income 2025 * | 11M | EV / Sales 2024 * | 2.49 x |
Net Debt 2024 * | 19.91B | Net Debt 2025 * | 18.33B | EV / Sales 2025 * | 2.36 x |
P/E ratio 2024 * |
15
x | P/E ratio 2025 * |
469
x | Employees | 20,270 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.64% |
Latest transcript on Bausch Health Companies Inc.
1 day | +1.96% | ||
1 week | +1.63% | ||
Current month | -0.11% | ||
1 month | +10.22% | ||
3 months | +28.85% | ||
6 months | +10.09% | ||
Current year | +16.96% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 22-05-23 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 08-07-31 |
John Paulson
CHM | Chairman | 68 | 17-05-31 |
Steven Miller
BRD | Director/Board Member | 35 | 21-03-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.26% | 18 M€ | +4.89% | - | |
0.24% | 1 M€ | -.--% | - | |
0.13% | 3 M€ | +1.80% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 9.38 | +1.96% | 1,195,811 |
24-03-15 | 9.2 | +1.21% | 1,385,517 |
24-03-14 | 9.09 | -2.05% | 1,037,885 |
24-03-13 | 9.28 | +0.98% | 1,075,220 |
24-03-12 | 9.19 | +0.77% | 1,027,329 |
Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.96% | 3.36B | |
+30.83% | 679B | |
+30.96% | 589B | |
+0.01% | 381B | |
+15.18% | 314B | |
+11.39% | 308B | |
+0.78% | 212B | |
-6.09% | 210B | |
-2.92% | 203B | |
-3.72% | 158B |